Testing effectiveness (Phase 2)Study completedNCT04816721What this trial is testingEvaluate EDP 938 Regimens in Children With RSVWho this might be right forRespiratory Syncytial Virus (RSV) Enanta Pharmaceuticals, Inc 99
Large-scale testing (Phase 3)Study completedNCT06593587What this trial is testingAssess the Safety, Tolerability, and Immunogenicity of RSVpreF in Older Adults in KoreaWho this might be right forRespiratory Syncytial Virus Pfizer 378
Testing effectiveness (Phase 2)Study completedNCT04196101What this trial is testingAssess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult SubjectsWho this might be right forRespiratory Syncytial Virus Enanta Pharmaceuticals, Inc 82
Large-scale testing (Phase 3)Study completedNCT06067230What this trial is testingInvestigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk AdultsWho this might be right forRespiratory Syncytial Virus ModernaTX, Inc. 1,153
Testing effectiveness (Phase 2)Study completedNCT00632463What this trial is testingRI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV IllnessWho this might be right forUpper Respiratory Tract InfectionLower Respiratory Tract Infection ADMA Biologics, Inc. 21
Not applicableStudy completedNCT02755948What this trial is testingCell Mediated Immunity Against RSV and Influenza in a Human Experimental ChallengeWho this might be right forRespiratory Syncytial Virus InfectionsInfluenza, Human Imperial College London 75
Not applicableActive Not RecruitingNCT03698084What this trial is testingRESCEU: Defining the Burden of RSV DiseaseWho this might be right forRespiratory Syncytial Virus InfectionsRSV Infection University of Oxford 2,000
Large-scale testing (Phase 3)Study completedNCT00076973What this trial is testingAn Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)Who this might be right forBronchiolitis Organon and Co 1,125
Early research (Phase 1)Study completedNCT03473002What this trial is testingA Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy AdultsWho this might be right forAntiviral ProphylaxisRespiratory Syncytial Virus Infection National Institute of Allergy and Infectious Diseases (NIAID) 21
Testing effectiveness (Phase 2)Ended earlyNCT03699202What this trial is testingAnti-RSV Study in Chinese Patients (ASCENT)Who this might be right forRespiratory Syncytial Virus Infections Shanghai Ark Biopharmaceutical Co., Ltd. 1
Not applicableStudy completedNCT02132923What this trial is testingA Study in Japanese Children Hospitalized With Respiratory Syncytial Virus Related Lower Respiratory Tract InfectionsWho this might be right forRespiratory Syncytial Virus Janssen R&D Ireland 49
Early research (Phase 1)Study completedNCT03624790What this trial is testingInpatient Challenge Study of rRSV A/Maryland/001/11, a Human Respiratory Syncytial Virus Challenge Strain, Administered to Healthy Adult VolunteersWho this might be right forRespiratory Syncytial Virus Infections National Institute of Allergy and Infectious Diseases (NIAID) 40
Large-scale testing (Phase 3)Study completedNCT02968173What this trial is testingAssess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of BelarusWho this might be right forRespiratory Syncytial Virus (RSV) AbbVie 50
Early research (Phase 1)WithdrawnNCT06666179What this trial is testingSafety and Immunogenicity Study of SCB-1019T in ChildrenWho this might be right forRSV Infection Clover Biopharmaceuticals AUS Pty
Not applicableEnded earlyNCT04431050What this trial is testingEvaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory PathogensWho this might be right forHuman InfluenzaRespiratory Syncytial Virus InfectionsRhinoviral Infections+3 more Imperial College London 6
Early research (Phase 1)Study completedNCT02794870What this trial is testingEvaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of AgeWho this might be right forRespiratory Syncytial Virus Infections National Institute of Allergy and Infectious Diseases (NIAID) 33
Early research (Phase 1)Study completedNCT02289820What this trial is testingEvaluate the Safety and Immunogenicity of MEDI7510 in Older AdultsWho this might be right forRespiratory Syncytial Virus (RSV) MedImmune LLC 363
Not applicableEnded earlyNCT01159795What this trial is testingStudying Innate Immune Responses in Infants With BronchiolitisWho this might be right forBronchiolitis Imperial College London 250
Not applicableNot Yet RecruitingNCT07505420What this trial is testingRisk Factors and Severity of Bronchiolitis in Hospitalized Children at Assiut University HospitalWho this might be right forBronchiolitisAcute BronchiolitisRespiratory Syncytial Virus Infection Assiut University 65
Early research (Phase 1)Study completedNCT06850051What this trial is testingA Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.Who this might be right forHealthy VolunteersInfluenza VaccinationRespiratory Syncytial Virus Vaccination+2 more Sanofi 270